Possible Biomarkers for Cancer Immunotherapy.

Otoshi, Takehiro; Nagano, Tatsuya; Tachihara, Motoko; Nishimura, Yoshihiro

Otoshi, Takehiro; Nagano, Tatsuya; Tachihara, Motoko; Nishimura, Yoshihiro.

Afiliación

Otoshi T; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Hyogo 650-0017, Japan.
Nagano T; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Hyogo 650-0017, Japan. tnagano@med.kobe-u.ac.jp.
Tachihara M; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Hyogo 650-0017, Japan.
Nishimura Y; Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Hyogo 650-0017, Japan.

Cancers (Basel) ; 11(7)2019 Jul 03.

Article en En | MEDLINE | ID: mdl-31277279

Palabras clave

cancer immunotherapy; gut microbiome; mismatch repair status; neoantigens; programmed cell death-ligand 1 expression; specific gene mutations; tumor mutational burden

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2019 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google